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  Outer membrane proteins of Pasteurella (P.) multocida have 
been  known  to  be  protective  immunogens.  Pasteurella 
lipoprotein E (PlpE) has been reported to be an important 
cross reactive outer membrane protein in P. multocida. The 
gene encoding the PlpE of P. multocida serotypes A: 3, B: 2 
and D: 1 was amplified from the genomic DNA. The amplified 
products  were  cloned  and  the  nucleotide  sequence  was 
determined. Sequence analysis of the recombinant clones 
revealed a single open reading frame of 1,011 bp, 1,008 bp and 
1,017 bp encoding a protein with a calculated molecular mass 
of 37.829 kDa, 37.389 kDa and 37.965 kDa for serotypes A: 
3, B: 2 and D: 1 respectively. The comparison of the plpE 
sequence in different capsular types revealed a high degree 
(＞90%)  of  homology.  Furthermore,  the  plpE  gene  of 
Haemorhhagic  septicaemia  causing  serotype  (B:  2)  was 
expressed in E. coli and recombinant PlpE was strongly 
immunostained by antiserum against whole cell antigen, 
indicating that the protein is expressed in vivo. 
Keywords: Haemorhhagic septicaemia, Pasteurella multocida, 
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Introduction
  The population of cattle and buffaloes in India is the 
largest in the world and represents a large portion of the 
Indian livestock industry. Hemorrhagic septicaemia (HS) 
is an economically important disease responsible for a high 
morbidity and mortality in cattle and buffaloes in India and 
other parts of Asia and Africa [8]. In India alone, it is 
estimated to cause economic losses of more than 10 million 
rupees annually [23]. HS is primarily caused by serotypes 
B: 2 and E: 2 of Pasteurella (P.) multocida. Besides B: 2, 
several other serotypes are associated with sporadic 
outbreaks of disease, particularly in feral ruminants [12]. 
Apart from HS causing serotype B: 2, serotype A has also 
been associated with HS like conditions in ruminants [14]. 
The organism is also responsible for bovine pneumonia, 
porcine pneumonia, fowl cholera, and snuffles in livestock 
and poultry [22]. 
    Considering its significance as an important animal 
pathogen, research has been focused mainly on identifying 
the immunogens of P. multocida that can elicit cross- 
protective immunity and thus be used in vaccines against 
Pasteurellosis. Membrane antigens have been identified as 
potential immunogens and shown to elicit protective 
immune responses. It has been recognized that in vivo- 
grown P. multocida and membrane-associated proteins of 
in vivo grown cells can induce cross-protective immunity 
[10]. Partially purified membrane proteins, prepared from 
in vivo grown cells with apparent molecular weight of 39 
kDa and 59 to 65 kDa have been reported to be associated 
with cross-protective immunity [20]. 
  Outer membrane protein (OMP) profiling and western 
blot analysis have shown several immunogenic proteins in 
the outer membrane fractions of P. multocida [3,7,13,15]. 
Among these, a 39 kDa protein has been reported to be 
highly immunogenic and cross protective, when challenged 
with heterologous strains [11,21]. The monoclonal antibodies 
to this protein were found to be protective in mice against 
lethal challenge with virulent strains [2]. Later, Wu et al. 
[25] recognized 39 kDa cross protective immunogen as 
Pasteurella lipoprotein E (PlpE). They also reported the 
protective nature of recombinant PlpE (r- PlpE) against a 
challenge infection with virulent P. multocida strain X-73 
serotype A: 1, in mice and chickens. PlpE has also been 228    Ajay Pratap Singh et al.
reported in other bacterial species [19].
  Confer et al. [5] vaccinated cattle with recombinant PlpE 
of Mannheimia haemolytica which resulted in reduced 
severity of lung lesions in experimental study with virulent 
M. haemolytica. The plpE gene of P. multocida Pm70 
encodes a lipoprotein of 335 amino acids and has 24.3% 
sequence homology with the plpE gene of M. haemolytica 
[17]. Nevertheless the major epitopes of the PlpEs of M. 
haemolytica and P. multocida Pm70 share no homology. 
  In this study, we described the molecular cloning and 
characterization of the plpE gene of P. multocida capsular 
type A: 3, B: 2 and D: 1 in order to determine the 
heterogeneity among these. Additionally, prokaryotic 
expression and purification of PlpE was carried out for 
immunological study. 
Materials and Methods
Bacterial strain
  Three isolates viz. P. multocida serotypes A: 3, B: 2 
(vaccine strain P52) and D: 1 maintained in the Division of 
Bacteriology and Mycology, Indian Veterinary Research 
Institute, were employed as sources of the plpE gene. 
Escherichia coli (strain JM109) used as host for molecular 
cloning and expression of plpE gene, was grown in either 
Luria Bertani broth (Himedia Laboratories, India) at 37
oC 
or Luria Bertani agar containing ampicillin at a final 
concentration of 50 μg/mL.
Preparation of OMPs from P. multocida P52 
  The OMPs were extracted by the method described by 
Choi-Kim et al. [4]. Briefly the P. multocida serotype B: 
2 (P-52) cells were grown in BHI broth (Himedia 
Laboratories, India), harvested and washed twice using 
sterile PBS (pH7.2). The cells were then suspended in 10 
mM HEPES (pH 7.4) and disrupted by sonication, five 
jerks at 10 micron for 2 min each, at 30 sec intervals. The 
cell debris was removed by centrifugation at 1,700 × g for 
20 min. The sonicated supernatant was then centrifuged at 
100,000 × g at 4
oC for 60 min. The resultant Pellet was 
resuspended in 2 mL of 2% (W/V) sodium lauryl 
sarcosinate (Sigma, USA) in 10 mM HEPES (pH 7.4) and 
incubated at 22
oC for 60 min. The insoluble OMPs were 
sedimented by centrifugation at 100,000 × g at 4
oC for 60 
min and the pellet was dissolved in PBS.
Preparation of polyclonal antibody to whole cell antigen 
  The whole cell method was employed to raise the hyper 
immune sera against P. multocida B: 2 [24]. The P. 
multocida B: 2 organisms were grown in casein sucrose 
yeast extract agar plate and the growth was harvested into 
PBS containing 0.3% formalin and turbidity was adjusted 
by Mac Farland’s tube number 4. Rabbits were inoculated 
intravenously at 3∼4 day intervals with 0.2, 0.5, 0.75, 1.0, 
1.5 and finally 2.0 mL. One week after the final injection, a 
booster dose (0.5 mL of live culture) was given intravenously. 
The animals were bled after 10 days and the serum separated. 
Amplification of plpE gene by PCR
  Genomic DNA of P. multocida serotypes A: 3, B: 2 and D: 
1 were isolated using DNA isolation kit (Qiagen, USA). 
The plpE genes from all three serotypes were amplified by 
PCR using specific primers 5´-CCATGGGCATGAAACA 
AATCGTTTTAAA-3´ (sense primer) and 5´-CTCGAGT 
TGTGCTTGGTGACTTTTTTC-3´ (antisense primer). The 
PCR mixture consisting of 50 ng of template, 25 pmol of 
each of the primers, 200 μM of dNTPs mix, × 1 PCR buffer, 
1.5 mM MgCl2 and 1 U of Taq DNA polymerase (MBI 
Fermentas, USA) were diluted to a 25 μL volume with 
milliQ water. PCR was performed with the initial 
denaturation at 94
oC for 10 min followed by 30 cycles of 
denaturation at 94
oC for 45 sec, annealing at 53
oC for 45 
sec, extension at 72
oC for 1 min and final extension at 72
oC 
for 10 min. The amplified product was visualized by 
electrophoresis through 2% agarose gel (Bangalore Genei, 
India) prepared in × 1 Tris Acetate EDTA buffer and 
photographed.
Cloning, sequencing and analysis
  The agarose gel containing DNA fragments was excised 
and the gel extraction of DNA fragments was carried out 
using Min Elute Gel extraction kit (Qiagen, USA). The Taq 
DNA polymerase-generated PCR products from each 
serotype were separately ligated to pDrive TA cloning 
vector (Qiagen, USA) and transformed into E. coli JM109 
by rapid DNA ligation and a transformation kit (MBI 
Fermentas, USA). Preliminary identification of recombinant 
clones was done by blue/white screening. Plasmid isolation 
was carried out using Plasmid miniprep kit (Quiagen, 
USA) and the clones were confirmed by restriction 
digestion using NcoI and XhoI restriction endonuclease 
(MBI Fermentas, USA). The confirmed clones were then 
used for sequencing of the inserted gene. The obtained 
sequences were compared with the reported plpE gene of 
other P. multocida serotypes viz. X-73 (A: 1), P-470 (A: 3), 
P-1059 (A: 3), P-1662 (A: 4), P-61 (D: 3) and ATCC 12948 
(D: 11), using DNAStar software (DNASTAR, USA). 
Secondary structure predictions and physiochemical 
properties of PlpE in the form of the algorithm were 
generated with the Protean program (DNAStar, USA). 
Prokaryotic expression of plpE gene of P. multocida B: 2
  The truncated form of plpE gene without the sequence 
encoding the putative signal peptide was amplified using 
genomic DNA of P. multocida serotype B: 2. The 
oligonucleotide sequence for the forward primer was 5´-C 
CATGGCATGTAGCGGTGGTGGC-3´ starting 58 
nucleotides downstream of the 5´ end and 5´-CTCGAGTT Molecular characterization of plpE gene of Pasteurella multocida    229
Fig. 1. SDS-PAGE of outer membrane preparation. Lane M 
represents protein molecular weight marker. The most prominent
band corresponding to molecular weights of 39 kDa and 32 kDa
is indicated.
ATTGTGCTTGGTGAC-3´ for reverse primer. The 960 bp 
amplimer thus obtained was digested with restriction 
enzymes NcoI and XhoI before cloning into expression 
vector pPRO.EX.HTb, which was double digested with the 
same enzyme pair. The digested fragments were ligated 
followed by transformation into competent E. coli JM109. 
Subsequently the transformed cells were plated on LB agar 
containing ampicillin (50 μg/mL). The recombinant 
plasmids were identified by restriction endonuclease 
analysis. For the synthesis of recombinant protein, a single 
colony of E. coli JM109 harboring the plpE gene in 
pPRO.EX.HTb was inoculated into 100 mL of LB broth 
supplemented with ampicillin and incubated with shaking 
at 37
oC until the culture reached an OD of 0.4 to 0.6 at A600 
nm (∼4 h incubation). Mid log phase culture was induced 
by 1 mM isopropyl β-D-1- thiogalactopyranoside (IPTG) 
(Sigma, USA) and 1 mM MgCl2. The induced culture was 
incubated at 30
oC for 6 h with vigorous shaking (300 rpm). 
Purification of recombinant protein
  The culture was harvested and lysed by using lysis buffer 
(100 mM NaH2PO4, 10 mM Tris, 8 M urea, pH 8.0). The 
bacterial lysate was centrifuged at 10,000 × g for 30 min at 
4
oC to remove insoluble cellular debris. The supernatant 
containing the recombinant protein was loaded onto affinity 
column packed with nickel chelating resin (Qiagen, USA) 
that selectively binds recombinant proteins with 6 histadine 
residues (His-Tag). The lysate was washed with 10 ml of 
wash buffer (100 mM NaH2PO4, 10 mM Tris, 8 M urea, pH 
6.3) for removing the non-specific proteins. The recombinant 
protein bound to resin was then eluted with a low pH buffer.
SDS-PAGE and Western blots 
  Samples were analyzed on a polyacrylamide gel using 
gels of 12% acrylamide contents and 3.3% cross linking. 
The bacterial OMP preparation and purified recombinant 
PlpE were applied to 12% gels and electrophoresed at 
20mA. Before loading, samples were boiled for 3.5 min in 
an equal volume of buffer containing 2% SDS. Samples 
run under reducing conditions were boiled in the presence 
of 5% 2-mercaptoethanol. The gels were stained with 
Coomassie blue R-250 (Bio-Rad, USA) for detection of 
proteins. For Western blots, the proteins were transferred 
to Nitrocellulose membranes at 80 V for 2 h. The 
membranes were placed in 5 mL blocking buffer (5% Skim 
milk powder in TBS) and incubated at 4
oC overnight 
followed by washing twice with TBS-T [1 M Tris HCl (pH 
8.0), 5 M NaCl, and Tween 20 (0.05%)] for 10 min each. 
Subsequently, the membranes were probed with hyper 
immune sera raised against P. multocida serotype B: 2 
diluted in blocking buffer (1 : 500) and washed. Rabbit 
anti-goat peroxidase-conjugate (diluted 1 : 5,000) (Sigma, 
USA) was used as secondary antibody. The blots were 
developed by adding chromogenic substrate solution 
(Bio-Rad, USA) for 5-10 min. The reaction was terminated 
by washing the membrane with distilled water.
Results
OMPs profiling and immunoblot analysis
  OMPs of P. multocida B: 2 were extracted and upon 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) separation, bands of apparent molecular 
weight 16, 27, 29, 32, 39 and 47 kDa proteins were 
observed in SDS-PAGE (Fig. 1). The polypeptides of 
approximate molecular weight 32 and 39 kDa were found 
to be major OMPs. On Western blots, 32 and 39 kDa 
proteins were identified as major immunodominant 
proteins, giving a strong immunostaining reaction with 
hyper-immune sera against whole cell antigen of P. 
multocida serotype B: 2 strain P52.
PCR, cloning and sequencing of the plpE gene
  The plpE gene from P. multocida serotype A: 3, B: 2 and 
D: 1 was successfully amplified using the plpE specific 
primers. A single PCR product with a molecular size of 
approximately 1 kb was amplified in all of the three 230    Ajay Pratap Singh et al.
Fig. 3. DNA identity matrix based on pair wise comparison of plpE sequences of different strains of Pasteurella multocida.
Fig. 2. The plpE gene amplified by PCR using genomic DNA of
P. multocida. Lane M represents DNA ladder and Lane 1-3 shows
an amplified plpE gene in P. multocida serotypes A: 3, B: 2 and
D: 3 respectively.
serotypes of P. multocida (Fig. 2). The amplified products 
were separately cloned into pDrive TA cloning vector 
(Qiagen, USA). The restriction digestion of each of the 
recombinant clones with NcoI and XhoI enzymes 
confirmed the presence of an approximately 1,010 bp 
sequence within the recombinant plasmid. 
Nucleotide sequence accession number
  The sequence data for the plpE gene of P. multocida 
serotypes A: 3, B: 2 and D: 1 have been submitted to the 
GenBank database and assigned the accession numbers 
GQ202239, GQ202240 and GQ202241.
Sequence analysis of P. multocida plpE gene
  The nucleotide sequence of plpE revealed a putative open 
reading frame, beginning with an ATG initiation codon 
which remained open to the end of the sequence obtained. 
The 1kb functional plpE gene was found to be 1,011 bp, 
1,008 bp and 1,017 bp in length for the P. multocida 
serotypes A: 3, B: 2 and D: 1, respectively. 
  The plpE gene of Indian isolates of P. multocida serotypes 
A: 3, B: 2 and D: 1 were aligned for homology with the 
reported sequence of P. multocida strains X-73 (A: 1), 
P-470 (A: 3), P-1059 (A: 3), P-1662 (A: 4), P-61 (D: 3), 
ATCC 12948 (D: 11) and the percentage of identity and 
divergence among nine strains of P. multocida has been 
depicted in Fig. 3. The result of phylogenetic tree analysis 
showed close relationship between Indian isolate of P. 
multocida serotype A: 3 to the reported strain X-73, while 
serotype D: 1 was close to strain ATCC 12948. However, 
serotype B: 2 of P. multocida was found to be distantly 
related to the X-73 and ATCC 12948 strains of P. 
multocida. The detailed description of the isolates used in 
this study for plpE gene sequence comparison has been 
depicted in Table 1.
Analysis  of  amino  acid  sequence  and  secondary 
structure predictions
    The deduced sequences of PlpEs of P. multocida 
serotypes A: 3, B: 2, and D: 1 were found to contain 336, 
335 and 338 amino acids, respectively, having predicted 
molecular masses of 37.829, 37.389 and 37.965 kDa, 
respectively. When the amino acid sequences were compared 
it was observed that two amino acids (both serine) were 
found missing at the 26th and 27th position in the P. 
multocida serotype A: 3 when compared to serotype D: 1. 
Additionally, methionine was found missing at the 59th 
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Fig. 4. Hydrophilicity, antigenicity and surface probability plot of deduced amino acid sequence of PlpE of P. multocida strain P-52 
(serotype B: 2). Positive values represent hydrophilic, antigenic and surface exposed regions.
Table 1. Details of the isolates included in the plpE gene sequence comparison
Isolates Serotype Host species
No. of 
nucleotides (bp)
Molecular mass 
of protein (Da)
Isoelectric 
point
Gene bank 
accession number
Pasteurella multocida
  X-73
  P-1059
  P-1662
  P-470 
  P-61 
  ATCC 
  12948 
  BNM-P52
  BNM-194
  BNM-47
A: 1
A: 3
A: 4
A: 3
D: 3
D: 11
B: 2
A: 3
D: 1
Chicken
Turkey
Turkey
Pig
Pig
Pig
Cattle
Buffalo
Buffalo
1,011 
1,008 
1,008 
1,008 
1,008 
1,017 
1,008 
1,011 
1017 
37738.64
37413.26
37546.41
37441.28
37413.26
37389.25
37829.71
37965.99
5.89
6.19
5.81
6.19
6.19
5.81
5.89
6.34
EF219452
EF219455
EF219456
EF219453
EF219454
EF219457
GQ202239
GQ202240
GQ202241
Mannheimia haemolytica
  89010807N S1 Sheep 1,310 39127.82 6.65 AF059036
Fig. 5. Expression and purification of r-PlpE in E. coli JM109. 
Lane M represents protein molecular weight marker, Lane 1 
contains lysis buffer follow through, Lane 2 contains wash buffer
follow through and Lanes 3-7 contains first, second, third, fourth
and fifth eluted fractions.
    The physiochemical analysis of PlpE using Protean 
software showed a typical hydrophobic stretch at the N 
terminus, which corresponded to the putative signal 
peptide. The protein sequences following signal peptide 
had predominant hydrophilic regions, with smaller 
intervening hydrophobic stretches throughout the protein. 
The predicted protein had predominant antigenic indices 
throughout the length and region with probable antigenic 
determinant of protein was observed between 1-28 amino 
acids (Fig. 4).
Expression of plpE gene of P. multocida serotype B: 2
  The ∼960 bp plpE gene product without signal peptide 
sequence was amplified from P. multocida genome and 232    Ajay Pratap Singh et al.
Fig. 6. Immunoblot of purified PlpE probed with hyperimmune 
serum against whole cell lysate of P. multocida serotype B: 2 and
rabbit anti-goat peroxidase conjugate. 39 kDa bands corresponding
to r-PlpE are indicated. Lane M contains prestained protein 
molecular weight marker.
cloned directionally in expression vector pPRO.EX.HTb. 
The recombinant E. coli Jm109 cells were induced by 
IPTG and the expressed PlpE fused with polyhistadine tag 
was purified by nickel chelating affinity chromatography. 
SDS-PAGE electrophoresis of the eluted fraction showed a 
very intense protein band of ∼39 kDa (Fig. 5). Western 
blot analysis using homologous hyper immune serum 
against whole cell antigen further confirmed the antigenicity 
of 39 kDa recombinant PlpE (Fig. 6).
Discussion
    In this study, we characterized the plpE gene of P. 
multocida serotypes A, B and D followed by expression 
and immunoblot of the PlpE of P. multocida P52 (the 
vaccine strain used in India). OMPs have been found to be 
potent immunogens and protective to mice, rabbits, 
chicken and calves [6,16,26]. A 39 kDa cross-protective 
antigen was identified by Rimler [20] in P. multocida A: 
3 (strain P1059) which induced active and passive cross- 
protection in chickens and turkeys [11,21]. The 
monoclonal antibodies against 39 kDa protein of P. 
multocida P-1059 (serovar A: 3) were produced and 
characterized by Ali et al. [1,2]. Mice passively immunized 
with the monoclonal antibodies to 39 kDa protein were 
found resistant to lethal challenge with virulent strains. In 
2007, Wu et al. [25] observed that mice immunized with 
purified recombinant PlpE (r-PlpE) was resistant to 
homologous and heterologous challenge with P. multocida. 
Also, the r-PlpE was found to confer good protection 
against challenge infection with P. multocida strain X-73 
(A: 1) in chickens. 
  The plpE genes of A: 3, B: 2 and D: 1 serotypes of P. 
multocida were amplified using the primers designed on 
the sequence of the plpE gene of P. multocida A: 3 which 
was approximately 1kb in all the three isolates. Upon 
comparison with reported sequences of plpE gene of P. 
multocida strains X-73 (A: 1), P-470 (A: 3), P-1059 (A: 3), 
P-1662 (A: 4), P-61 (D: 3), ATCC 12948 (D: 11), more than 
90% homology was observed with Indian isolates of P. 
multocida serotypes A: 3. B: 2 and D: 1. The result showed 
the presence of plpE gene in all three serotypes of Indian 
isolates. The nucleotide sequence of HS causing P. 
multocida serotype B: 2 had 92.8% and 94.4% identity 
with other Indian isolates of P. multocida serotypes A: 3 
and D: 1 respectively. The finding indicated that Indian 
isolates of P. multocida are closely related to each other and 
also to other strains on the basis of the plpE gene sequence. 
Wu  et al. [25], also observed 90.8-100% sequence 
homology of the plpE gene, shared by different strains of P. 
multocida serotypes. 
  The nucleotide sequences of the Indian isolates of P. 
multocida serotypes A: 3, B: 2 and D: 1 were converted to 
amino acids and compared for homology. The amino acid 
sequence showed variation in composition among 
serotypes A: 3, B: 2 and D: 1. The absence of one or 
more amino acids may attribute to the difference in 
immunogenicity of the PlpE among these serotypes; this 
can be confirmed by detailed proteomic analysis of the 
recombinant protein.
  The predominant hydrophilic regions were found dispersed 
throughout the length of protein. The above finding was 
further supported by surface probability assay of the PlpE, 
by which it could be inferred that the PlpE has putative 
surface exposed regions randomly distributed throughout 
the protein. Similar findings have been reported in other 
PlpE of M. haemolytica and OmlA of A. pleuropneumoniae 
by Gerlach et al. [9] and Pandher et al. [19]. 
    The PlpE was expressed in E. coli JM109 and the 
apparent molecular mass of the expressed PlpE was found 
to be ∼39 kDa when analyzed by SDS-PAGE. Western 
Blot analysis revealed the presence of a single ∼39 kDa 
immunogenic band, indicating the antigenic and immuno-
dominant nature of the PlpE. This statement was further 
supported by the SDS-PAGE and immunoblot analysis of 
OMPs of P. multocida serotype B: 2 (P52). The OMPs were 
extracted and separated by SDS-PAGE, which revealed 
presence of major outer membrane fractions with molecular 
masses of approximately 39 kDa. Immunoblot of OMPs 
probed with hyperimmune sera against whole cell antigen Molecular characterization of plpE gene of Pasteurella multocida    233
of P. multocida P52 revealed a deeply immunostained band 
corresponding to a molecular weight of 39 kDa. The results 
clearly indicated that PlpE is most likely to be a 39 kDa 
cross protective immunodominant antigen, as described by 
Ibrahim et al. [11] and Rimler [21]. It also indicates a 
satisfactory level of expression of PlpE grown in in-vitro 
conditions.
  The findings of the present study revealed that PlpE is 
present in all three Indian isolates of P. multocida serotypes 
A: 3, B: 2 and D: 1. The antigenic uniformity in this protein 
and extent of amino acid similarity supports its cross 
protective nature among the three serotypes. The western 
blot analysis further confirmed that the PlpE is one of the 
major immunodominant proteins in P. multocida.
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